Key result
Medisafe smartphone app improves self-reported medication adherence but fails to reduce SBP versus controls.
Why the study?
Does a smartphone application improve medication adherence and blood pressure control in patients with uncontrolled hypertension?
RCT (n=411)
1:1
Does a smartphone application improve medication adherence and blood pressure control in patients with uncontrolled hypertension?
Effect estimate: Difference -0.5 (95% CI -3.7 to 2.7)
Absolute Event Rate: -10.6% vs -10.1%
p-value: p=.78
A smartphone medication adherence app slightly improved self-reported adherence but did not significantly reduce systolic blood pressure in patients with uncontrolled hypertension.
No takes yet. Share an insight, caveat, or question.
Does not support app use for BP control despite adherence gains; challenges translation of self-reported adherence to clinical outcomes.
Morawski et al. (2018) conducted an RCT in uncontrolled hypertension (n=411). Medisafe smartphone app vs. control was evaluated on change in systolic blood pressure at 12 weeks (Difference -0.5, 95% CI -3.7 to 2.7, p=.78). The Medisafe smartphone app improved self-reported medication adherence (difference 0.4; P=.01) but did not significantly reduce systolic blood pressure compared with controls (difference -0.5; P=.78).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: